Literature DB >> 30324074

Coincidence of Malignant Melanoma and an Incidently Discovered Parotid Mass Presenting a Diagnostic Challenge.

Handan Derebaşinlioğlu1, Sarper Yilmaz1.   

Abstract

Parotid masses coincided with skin tumors in head and neck region may represent a serious diagnostic challenge. Conventional imaging modalities such as computed tomography, magnetic resonance imaging may help to determine nature of the masses. Positron emission tomography - computed tomography imaging is reported to be useful for the detection of malignancy in the parotid gland. But in some situations all of them become insufficient. We present a case of cheek malignant melanoma with an incidentally discovered parotid mass during the investigation. We describe the problems experienced in the course of differential diagnosis and decision making in terms of surgical management. As a result, the most reliable diagnosis of suspicious parotid lesions accompanying head and neck melanomas comes from frozen section analyses. The other diagnostic tools are not reliable enough to allow a safe surgical plan in terms of regional treatment; however, the significance of positron emission tomography - computed tomography in distant metastasis investigation should always be kept in mind.

Entities:  

Year:  2018        PMID: 30324074      PMCID: PMC6181513          DOI: 10.1097/GOX.0000000000001897

Source DB:  PubMed          Journal:  Plast Reconstr Surg Glob Open        ISSN: 2169-7574


  31 in total

Review 1.  Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma.

Authors:  Sarah J Vinnicombe; Rodney H Reznek
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-04-23       Impact factor: 9.236

2.  The potential of 2-deoxy-2[18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes.

Authors:  R L Wahl; M S Kaminski; S P Ethier; G D Hutchins
Journal:  J Nucl Med       Date:  1990-11       Impact factor: 10.057

3.  Metastatic disease to the parotid gland.

Authors:  Michel Nuyens; Jonas Schüpbach; Edouard Stauffer; Peter Zbären
Journal:  Otolaryngol Head Neck Surg       Date:  2006-12       Impact factor: 3.497

4.  The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes.

Authors:  G C Basler; D J Fader; A Yahanda; V K Sondak; T M Johnson
Journal:  J Am Acad Dermatol       Date:  1997-03       Impact factor: 11.527

5.  Do nodal metastases from cutaneous melanoma of the head and neck follow a clinically predictable pattern?

Authors:  I Pathak; C J O'Brien; K Petersen-Schaeffer; E B McNeil; J McMahon; M J Quinn; J F Thompson; W H McCarthy
Journal:  Head Neck       Date:  2001-09       Impact factor: 3.147

6.  Clinical utility of 18F-FDG PET for patients with salivary gland malignancies.

Authors:  Jong-Lyel Roh; Chang Hwan Ryu; Seung-Ho Choi; Jae Seung Kim; Jeong Hyun Lee; Kyung-Ja Cho; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Nucl Med       Date:  2007-02       Impact factor: 10.057

7.  Accuracy of diagnosis of salivary gland tumors with the use of ultrasonography, computed tomography, and magnetic resonance imaging: a meta-analysis.

Authors:  Ying Liu; Jia Li; Yi-ran Tan; Ping Xiong; Lai-ping Zhong
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2014-11-14

8.  Fluorine-18 fluorodeoxyglucose positron emission tomography imaging of parotid mass lesions.

Authors:  T Okamura; J Kawabe; K Koyama; H Ochi; R Yamada; H Sakamoto; M Matsuda; Y Ohashi; Y Nakai
Journal:  Acta Otolaryngol Suppl       Date:  1998

9.  Neither MRI, CT nor US is superior to diagnose tumors in the salivary glands--an extended case study.

Authors:  Claudia Rudack; Sabine Jörg; Stephan Kloska; Wolfgang Stoll; Oliver Thiede
Journal:  Head Face Med       Date:  2007-04-03       Impact factor: 2.151

10.  Parotid incidentaloma identified by positron emission/computed tomography: when to consider diagnoses other than warthin tumor.

Authors:  Carolina Bothe; Alejandro Fernandez; Jacinto Garcia; Montserrat Lopez; Xavier León; Miquel Quer; Joan Lop
Journal:  Int Arch Otorhinolaryngol       Date:  2014-12-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.